Bildkälla: Stockfoto

Ascelia Pharma; Some takeaways from the investor update ahead of the US launch - Redeye

Ascelia is preparing and planning for the launch, and the activities are now expected to shift gear as the pivotal SPARKLE study is fully recruited.

Ascelia is preparing and planning for the launch, and the activities are now expected to shift gear as the pivotal SPARKLE study is fully recruited.
Börsvärldens nyhetsbrev
ANNONSER